CFR Head Chief Threatens To Drop Adcock Buy If Government Opposed
This article was originally published in PharmAsia News
Executive Summary
CFR Pharmaceuticals indicated it is not interested in buying Adcock Ingram if the South Africa company's largest shareholder, a government pension fund with an 18.6% stake, does not support the acquisition.